Chicago Says Drug Cos. Shouldn't Exit Opioid Bellwether Suit

By Lauraann Wood · June 23, 2020, 6:47 PM EDT

Johnson & Johnson and Teva Pharmaceuticals can't escape a Chicago bellwether case over their allegedly deceptive opioid marketing because earlier rulings have already largely upheld the allegations, the city argued Monday....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

City of Chicago v. Purdue Pharma L.P. et al.

Case Number

Court

Illinois Northern

Nature of Suit

370 Other Fraud

Date Filed

June 11, 2014

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Recent Articles By Lauraann

November 07, 2024
Ill. Judge Anticipates 'Massive' Outcome Investor Restitution
November 04, 2024
MultiPlan Judge Raises Eyebrows At Attys' Biz Flight Billing
October 31, 2024
Ill. Judge Doubts Hillrom's Bid For Rival's Communications
October 18, 2024
Ill. Justices Find Broad COVID Immunity For Health Facilities
October 15, 2024
Horizon Lodges 4-Fold Attack On Tepezza MDL Bellwethers
September 23, 2024
Edelson, Susman, Berger To Lead MultiPlan Collusion MDL
September 19, 2024
Outcome Exec Who Flipped Gets 7 Months For $1B Fraud Role
September 18, 2024
7th Circ. Questions Nixing $183M Eli Lilly Drug Rebate Verdict
September 04, 2024
Ill. Panel Backs Atty's Bid To Litigate Medical Record Fee Suit
August 21, 2024
Hillrom Says Funding Docs 'Plainly' Relevant In Antitrust Suit